Viberzi Increases Pancreatitis Risk
After two patients without a gallbladder died while taking the irritable bowel syndrome drug, Viberzi, the FDA warns all users about an increased risk of serious pancreatitis while on the medication. An FDA review found patients, especially without a gallbladder, have an increased risk of developing serious pancreatitis that could result in hospitalization or death.
Read More